Thanks for your confirmation. So IMU is dosing patients who are not going through chemo. That means, their immune system is not compromised yet. In that case, we may well yet be surprised after the first or second cohort where they also observe efficacy other than safety and tolerability.
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-52
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $364.4M | |||
| Open | High | Low | Value | Volume |
| 4.9¢ | 5.0¢ | 4.8¢ | $413.7K | 8.448M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 112 | 14818485 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 13411 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |